BMJ talk medicine

In our new season of Doctor Important, we'll be discussing topics that are not always talked about, and today, by popular request of our listners, we're talking about Coroner's Court and inquests - two things that strike terror into doctors, but are often not as bad as you may fear.

Our panel;

Clara Munro is a surgical trainee in the North East Deanery.

She's joined by her colleage Katie Strong, another surgical trainee. We also have returning to Doctor Informed Ayisha Ashmore, an Obs and Gynae registrar in the East Midlands.

Our Expert guest this week is Beth Walker, a former palliative care registrar who now works as an advisor for Medical Protection.

Starting university can be a really exciting and really nerve-wracking time. There are so many questions you might have before you start. How do you know what to pack? How do you make friends? How do you study? Is it really going to be the best time of your life?!

You might be just about to start university in the next week or two, or simply feel like indulging in the nostalgia of those first few weeks. Either way, join Sharp Scratch panel members new and old as we come together to discuss the sorts of things we were worried about or looking forward to before we started university.

Check us out on social media:

Twitter: twitter.com/BMJStudent

Instagram: www.instagram.com/bmj_student/

Facebook: www.facebook.com/BMJStudent/

This podcast is produced and edited by Dom Byrne and Duncan Jarvies.

Status epilepticus is a serious medical emergency. Fortunately, it is relatively rare but when it does occur it can cause a range of serious complications including focal neurological deficits, cognitive dysfunction, and behavioural problems. So it is important that we get the diagnosis and management of this condition right. In this BMJ Best Practice podcast on status epilepticus, Kieran Walsh talks to Dr. Rajiv Mohanraj, Consultant Neurologist and Honorary Senior Lecturer at the Manchester Centre for Clinical Neurosciences

-

The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

In this conversation with John Dickinson, MD, PhD, University of Nebraska Medical Center and Social Media Editor for Journal of Investigative Medicine, JIM editor, Dr. Richard McCallum, provides an overview of the incidence, symptoms, diagnosis and management of gastroparesis. This podcast is especially relevant for primary care physicians, gastroenterologists, and GI researchers. Gastroparesis is a common disorder frequently tied with diabetes but has vague symptoms that can be misdiagnosed. Dr. McCallum walks us through common diagnostic approaches and discusses promising new therapies to reduce the symptom burden.

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Professor Bradley J. Monk to discuss the ATHENA-MONO clinical trial. Prof. Monk is an international thought leader and clinical trialist who has developed and advocated for maintenance treatment in newly diagnosed advanced and recurrent ovarian cancer. ATHENA-MONO represents his fifth positive randomized phase 3 trial studying maintenance treatment and adds confidence to this efficacious and tolerable paradigm changing opportunity for all patients regardless of the molecular genotype (allcomers).

Highlights:

- Maintenance therapy is now the global standard of care in patients with advanced or recurrent epithelial ovarian cancer. This can include a PAPP inhibitor, bevacizumab, or the combination.

- Maintenance treatment is efficacious in all molecular subgroups and is tolerable without an impairment in the quality of life.

- Payers acknowledge the value of maintenance treatment as do consensus guidelines.

Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, Liverpool, UK interviews Professor Peter Malfertheiner, Gastroenterologist, who is senior Professor of Medicine at the Ludwig Maximilian University of Munich, Munich, Germany, on the paper 'Management of Helicobacter pylori infection—the Maastricht VI/Florence Consensus Report' published in paper copy in Gut in September 2022 and online at: https://gut.bmj.com/content/71/9/1724

Please subscribe to the Gut Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest podcast every month. If you enjoy our podcast, please consider leaving us a review or a comment on the Gut Podcast iTunes page (https://podcasts.apple.com/gb/podcast/gut-podcast/id330976727).

The 2013 ARUBA trial concluded that medical management alone is superior to medical management with interventional therapy for patients with unruptured brain arteriovenous malformations. A study was conducted to analyze AVM treatment and epidemiologic response to the ARUBA trial. Following ARUBA, there has been a stark decrease in interventions for uAVMs. Nationwide rAVM discharge incidence is inversely correlated with uAVM intervention rate. Less uAVM interventions may lead to a substantial increase in AVM rupture incidence.

In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque speaks with Dr. Evan Luther(1) and Dr. Robert Starke(2) about their paper "Unruptured arteriovenous malformation intervention rate is inversely correlated with ruptured AVM discharge incidence" - https://jnis.bmj.com/content/12/suppl_1/a163.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767

Thank you for listening!

This episode was produced by Leticia Amorim and edited by Brian O'Toole.

(1) Neurological Surgery, University of Miami, Miami, Florida, USA

(2) Department of Neurosurgery & Radiology, Miller School of Medicine, University of Miami, Miami, Florida, USA

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Devon Abt to discuss SLN mapping in endometrial hyperplasia. Devon is a fourth-year Resident in Obstetrics & Gynecology at Beth Israel Deaconess Medical Center/Harvard Medical School currently applying into Gynecologic Oncology fellowship.

Highlights:

- Fewer than 30% of patients with preoperative diagnosis of endometrial intraepithelial neoplasia had concurrent endometrial cancer on final pathology.

Endometrial stripe ≥20mm was associated with 2 times the risk of concurrent endometrial cancer.

- Routine SLND in all patients with preoperative diagnosis of endometrial intraepithelial neoplasia is not cost-effective and would result in overtreatment.

- Endometrial stripe may be a criterion for selectively using a sentinel lymph node algorithm in patients with preoperative diagnosis of endometrial intraepithelial neoplasia who are poor candidates for lymphadenectomy or at institutions where frozen section is not available or reliable.

In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by BJCA President Dr Fielder Camm from Oxford, UK. They discuss his recent publication in Heart concerning bullying of trainees in UK cardiology and what we can all do to improve things.

If you enjoy the show, please leave us a podcast review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2

This is our last episode of series 1 of Doctor Informed, and with it we're coming full circle. Clara will be talking to our first two guests, Mary Dixon-Woods and Bill Kirkup, having now heard from all of our other experts over this series.

In this first series, we've learned about speaking out, team work, compassionate leadership - all the things that are needed to help clinicians challenge the status quo, So in this episode, we'll be asking Mary how much she thinks things have changed, and Bill how he manages a career challenging the healthcare system.

Our guests

Mary Dixon-Woods is director of THIS Institute, and a Health Foundation Professor of Healthcare Improvement Studies in the Department of Public Health and Primary Care at the University of Cambridge. Her work is concerned with generating a high quality evidence-base to support the organisation, quality and safety of care delivered to patients.

For links to the work that Mary talked about visit https://www.thisinstitute.cam.ac.uk/

Bill Kirkup is a clinician turned investigator - he led investigations into failings at a maternity and neonatal unit in Morcambe Bay, into the Oxford paediatric cardiac surgery unit and into Jimmy Savile’s involvement with Broadmoor Hospital. He was also a member of the Hillsborough Independent Panel